Global Life Bioventure V Sarl 13D and 13G filings for Immunic, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 4:41 pm Purchase | 2022-12-20 | 13D | Immunic, Inc. IMUX | Global Life Bioventure V Sarl | 1,849,786 4.200% | 43,873 (+2.43%) | Filing |
| 2022-03-15 11:09 am Purchase | 2020-08-05 | 13D | Immunic, Inc. IMUX | Global Life Bioventure V Sarl | 1,805,913 9.030% | 434,419 (+31.67%) | Filing |